QNTM

MKT CAP:$21M

Quantum BioPharma Ltd.

Market Cap

$21M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.40-$3.61 (-51.50%)

Jul 15, 2026

52W High $29.2152W Low $2.10

Company Details

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of as...

Leadership

Zeeshan SaeedFounder

Co-Founder, CEO & Executive Non-Independent Co-Chairman

Anthony John DurkaczFounder

Co-Founder & Executive Non-Independent Co-Chairman

Donal Carroll CPA

Chief Financial Officer

Nathan Coyle CPA

Controller

Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs

Ashwini Joshi M.S.

Director of Pharmaceutical Development

Patrick Onyango Ph.D.

Director of Operations at U.S.

Jason David Sawyer

Head of Finance & Mergers and Acquisitions

Maryann Adesso

Corporate Secretary

Randell Mack

President of FSD BioSciences

IPO Date

Jun 8, 2018

Website

www.quantumbiopharma.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$31M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding